|Home||» Products||» Cancer Products||» SORAFENAT|
Sorafenat - Sorafenib
Sorafenat contains sorafenib, which is a small molecular inhibitor of several tyrosine protein kinases.
Natco Pharma Ltd.
Sorafenat is used for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer.
200 mg tablets.
Bottle of 120 Tablets
Sorafenat is a prescription drug and should be used under proper medical guidance and advice.